Adaptive Biotechnologies Corporation (ADPT)
USD 7.37
(-0.54%)
USD 7.37
(-0.54%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 164.36 Million USD | 814.58% |
| 2022 | 17.97 Million USD | 165.77% |
| 2021 | -27.32 Million USD | -75.45% |
| 2020 | -15.57 Million USD | 74.03% |
| 2019 | -59.96 Million USD | -111.85% |
| 2018 | 506.16 Million USD | 6.25% |
| 2017 | 476.37 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 166.43 Million USD | 558.86% |
| 2024 Q1 | 25.26 Million USD | -84.63% |
| 2023 Q2 | -5.71 Million USD | -151.2% |
| 2023 FY | 164.36 Million USD | 814.58% |
| 2023 Q4 | 164.36 Million USD | 1205.23% |
| 2023 Q3 | 12.59 Million USD | 320.2% |
| 2023 Q1 | 11.16 Million USD | -37.85% |
| 2022 Q4 | 17.97 Million USD | 116.56% |
| 2022 Q2 | 34.93 Million USD | 2824.65% |
| 2022 FY | 17.97 Million USD | 165.77% |
| 2022 Q1 | -1.28 Million USD | 95.31% |
| 2022 Q3 | -108.5 Million USD | -410.63% |
| 2021 Q1 | -74.06 Million USD | -375.56% |
| 2021 Q2 | -75.57 Million USD | -2.05% |
| 2021 Q3 | -9.24 Million USD | 87.76% |
| 2021 Q4 | -27.32 Million USD | -195.44% |
| 2021 FY | -27.32 Million USD | -75.45% |
| 2020 Q2 | -319.7 Million USD | -83.07% |
| 2020 Q4 | -15.57 Million USD | 96.54% |
| 2020 Q3 | -450.74 Million USD | -40.99% |
| 2020 Q1 | -174.64 Million USD | -191.22% |
| 2020 FY | -15.57 Million USD | 74.03% |
| 2019 Q4 | -59.96 Million USD | -16.46% |
| 2019 FY | -59.96 Million USD | -111.85% |
| 2019 Q3 | -51.49 Million USD | -6.26% |
| 2019 Q2 | -48.45 Million USD | 56.46% |
| 2019 Q1 | -111.29 Million USD | -102.24% |
| 2018 Q4 | -55.03 Million USD | 0.0% |
| 2018 Q1 | 192.15 Million USD | 0.0% |
| 2018 FY | 506.16 Million USD | 6.25% |
| 2017 FY | 476.37 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 393.829% |
| Alkermes plc | -166.73 Million USD | 198.578% |
| Agenus Inc. | 274.13 Million USD | 40.041% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 91.21% |
| Aptorum Group Limited | 1.35 Million USD | -12012.191% |
| Ardelyx, Inc. | 34.51 Million USD | -376.263% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -3740.374% |
| Bicycle Therapeutics plc | -481.46 Million USD | 134.139% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -354.52% |
| ChromaDex Corporation | -24.04 Million USD | 783.5% |
| Chimerix, Inc. | -25.51 Million USD | 744.151% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -2258.872% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 794.21% |
| CRISPR Therapeutics AG | -150.84 Million USD | 208.965% |
| Precision BioSciences, Inc. | -85.41 Million USD | 292.446% |
| Dyadic International, Inc. | -6.37 Million USD | 2677.069% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 1131.62% |
| Fortress Biotech, Inc. | 7.66 Million USD | -2044.397% |
| Lantern Pharma Inc. | -21.7 Million USD | 857.342% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 248.7% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 2023.968% |
| Incyte Corporation | -3.17 Billion USD | 105.177% |
| IO Biotech, Inc. | -140.69 Million USD | 216.822% |
| Jaguar Health, Inc. | 29.39 Million USD | -459.246% |
| Novavax, Inc. | -298.29 Million USD | 155.103% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -2979.783% |
| Opthea Limited | 28.15 Million USD | -483.746% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 1079.022% |
| ContextLogic Inc. | -232 Million USD | 170.848% |
| MiMedx Group, Inc. | -33.9 Million USD | 584.847% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -1512.241% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 7193.918% |
| NextCure, Inc. | -6.47 Million USD | 2637.718% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 425.475% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 2676.705% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -1251.347% |
| Vaxcyte, Inc. | -368.22 Million USD | 144.638% |
| PDS Biotechnology Corporation | -32.7 Million USD | 602.518% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -851.314% |
| Pharming Group N.V. | 109.8 Million USD | -49.692% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 1044.861% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 193.801% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 987.523% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 987.523% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 2415.042% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 2904.915% |
| Acelyrin, Inc. | -216.9 Million USD | 175.779% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 3029.771% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 9634.107% |
| Summit Therapeutics Inc. | 34.67 Million USD | -374.038% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 2516.111% |
| Senti Biosciences, Inc. | 1.74 Million USD | -9346.437% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 189.037% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 312.222% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 2811.448% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -164648.57% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -26073.249% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 240.43% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 197.703% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -48.253% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 2263.876% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 227.305% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -2284.011% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 167.819% |
| Immix Biopharma, Inc. | -17.5 Million USD | 1038.721% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 151.9% |
| MEI Pharma, Inc. | -3.7 Million USD | 4536.383% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -1213.788% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -1.624% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -491.401% |
| Fortress Biotech, Inc. | 7.66 Million USD | -2044.397% |
| Precigen, Inc. | -481 Thousand USD | 34272.142% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -1067.303% |
| AlloVir, Inc. | -62.69 Million USD | 362.183% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 395.551% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -166.546% |
| ImmuCell Corporation | 10.99 Million USD | -1395.538% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 206.631% |
| Onconetix, Inc. | 5.33 Million USD | -2982.996% |
| PureTech Health plc | -167.19 Million USD | 198.308% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 639.619% |
| Elevation Oncology, Inc. | -19.11 Million USD | 959.755% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 3448.299% |
| Seer, Inc. | -4.24 Million USD | 3976.604% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 783.812% |
| Innoviva, Inc. | 255.56 Million USD | 35.684% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 394.229% |
| ESSA Pharma Inc. | -33.62 Million USD | 588.876% |
| GlycoMimetics, Inc. | -40.98 Million USD | 501.05% |
| GT Biopharma, Inc. | -1.02 Million USD | 16198.727% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 342.491% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -168.325% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 222.59% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 1286.259% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 669.299% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 218285.681% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 632.59% |
| Aptose Biosciences Inc. | -8.19 Million USD | 2105.746% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 5353.022% |
| Soligenix, Inc. | -4.95 Million USD | 3419.495% |
| Century Therapeutics, Inc. | 847 Thousand USD | -19305.903% |
| Kura Oncology, Inc. | -20.11 Million USD | 917.02% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 501.622% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 2057.228% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -8922.806% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 5241.32% |
| Autolus Therapeutics plc | -186.59 Million USD | 188.086% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 433.377% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 159.598% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -379.654% |
| GRI Bio, Inc. | -1.79 Million USD | 9262.096% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 1929.758% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 594.236% |
| IGM Biosciences, Inc. | -72.6 Million USD | 326.383% |
| INmune Bio, Inc. | -25.41 Million USD | 746.838% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -8.888% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 424.46% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 1111.534% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 5797.477% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -332.377% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 499.097% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -415.503% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 56.511% |
| Verastem, Inc. | -37.27 Million USD | 540.925% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 1911.617% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 416.933% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 1186.013% |
| Histogen Inc. | -7.48 Million USD | 2295.379% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 860.723% |
| Surrozen, Inc. | -32.66 Million USD | 603.208% |
| Organovo Holdings, Inc. | -1.5 Million USD | 11006.968% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 4010.276% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -766.91% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -6183.18% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -3854.957% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 2061.163% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 478.362% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 1227.595% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 151.886% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 22863.759% |
| Apollomics, Inc. | -27.39 Million USD | 699.993% |
| Amarin Corporation plc | -191.04 Million USD | 186.039% |
| Mesoblast Limited | 55.96 Million USD | -193.708% |
| Turnstone Biologics Corp. | -14.58 Million USD | 1227.043% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 749.881% |
| Synaptogenix, Inc. | -28.66 Million USD | 673.48% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 17660.684% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -237.29% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 19166.245% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 2362.128% |
| Exelixis, Inc. | -73.05 Million USD | 325.008% |
| Better Therapeutics, Inc. | -860 Thousand USD | 19212.558% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 784.496% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 168.098% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -22230.606% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 2309.801% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -13007.496% |
| Gritstone bio, Inc. | 39.49 Million USD | -316.227% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 295.441% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 6344.653% |
| Avid Bioservices, Inc. | 169.72 Million USD | 3.158% |
| Insmed Incorporated | 721.62 Million USD | 77.222% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 1898.04% |
| MediWound Ltd. | -5.32 Million USD | 3188.463% |
| OmniAb, Inc. | 9.2 Million USD | -1686.026% |
| Alector, Inc. | -35.63 Million USD | 561.229% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -91.19% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 3435.39% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -1141.544% |
| Zai Lab Limited | -775 Million USD | 121.209% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 51.735% |
| Aura Biosciences, Inc. | -21.52 Million USD | 863.614% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 299.282% |
| Immunic, Inc. | -45.34 Million USD | 462.523% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 185.07% |
| Veracyte, Inc. | -203.82 Million USD | 180.642% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 74.249% |
| FibroGen, Inc. | 56.76 Million USD | -189.549% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -1745.795% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 5914.051% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 8039.148% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 96.419% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 5019.725% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 199.038% |
| TG Therapeutics, Inc. | 17.86 Million USD | -820.211% |
| Galecto, Inc. | -21.21 Million USD | 874.736% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 791.057% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 89.527% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 771.657% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 1528.417% |
| XBiotech Inc. | -200.02 Million USD | 182.175% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 295.441% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -3530.035% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 566.12% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 312.862% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -2788.209% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 196.452% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 277.938% |
| Vaxxinity, Inc. | 10.13 Million USD | -1522.266% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 77.675% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 1626.512% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 349.209% |
| NexImmune, Inc. | -3.13 Million USD | 5345.269% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 4860.601% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 1187.705% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 706.524% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 1931.183% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 132043.007% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 505.127% |
| Ainos, Inc. | 4.07 Million USD | -3930.674% |
| Pluri Inc. | 22.82 Million USD | -619.997% |
| Prothena Corporation plc | -608.34 Million USD | 127.019% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 238.408% |
| Celularity Inc. | 65.19 Million USD | -152.137% |
| Rallybio Corporation | -24.1 Million USD | 781.968% |
| Cue Biopharma, Inc. | -33.81 Million USD | 586.023% |
| MeiraGTx Holdings plc | -40.3 Million USD | 507.841% |
| Omeros Corporation | 331.17 Million USD | 50.368% |
| Humacyte, Inc. | -22.48 Million USD | 830.979% |
| Immunocore Holdings plc | -358.59 Million USD | 145.837% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 768.842% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 631.918% |
| Blueprint Medicines Corporation | 702.83 Million USD | 76.614% |
| CalciMedica, Inc. | -5.53 Million USD | 3072.297% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 187.328% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 1709.242% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 510.54% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 594.295% |
| Pulmatrix, Inc. | -10.41 Million USD | 1677.882% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 2850.008% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 530.937% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 247.545% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 374.203% |
| Cytokinetics, Incorporated | 642.37 Million USD | 74.412% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 2922.737% |
| Nutriband Inc. | -251.65 Thousand USD | 65414.297% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 581.749% |
| Vor Biopharma Inc. | 4.3 Million USD | -3722.512% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 102.723% |
| Evogene Ltd. | -19.63 Million USD | 937.16% |
| ProKidney Corp. | -56.23 Million USD | 392.283% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 437.705% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 1879.416% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 87.949% |
| CorMedix Inc. | -43.05 Million USD | 481.785% |
| BioLineRx Ltd. | 7.33 Million USD | -2140.567% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 698.464% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -256.184% |
| Atai Life Sciences N.V. | -28.55 Million USD | 675.559% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -7269.014% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 820.407% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -826.8% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 318.941% |
| MediciNova, Inc. | -50.78 Million USD | 423.664% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 308.576% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 730786.824% |
| GeoVax Labs, Inc. | -6.45 Million USD | 2647.319% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 182.258% |
| Biomea Fusion, Inc. | -166.57 Million USD | 198.678% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 191.839% |
| Mereo BioPharma Group plc | -51.46 Million USD | 419.353% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 273.304% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 155.953% |
| Absci Corporation | -72.59 Million USD | 326.408% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -3499.825% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 170.112% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 274.468% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 271.761% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 520.669% |
| Allakos Inc. | -24.97 Million USD | 758.13% |
| Imunon, Inc. | -4.21 Million USD | 4000.659% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 1214.964% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 221.394% |
| BioAtla, Inc. | -109.01 Million USD | 250.781% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -22230.606% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 17604.579% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -1273.625% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 875.211% |
| XOMA Corporation | -29 Million USD | 666.786% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 1092.56% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 1923.07% |
| aTyr Pharma, Inc. | -7.44 Million USD | 2306.578% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 231.878% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 178.961% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 300.99% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 277.191% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 19230.71% |
| Akari Therapeutics, Plc | -3.84 Million USD | 4374.85% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -10028.105% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 88.097% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 13934.118% |
| UroGen Pharma Ltd. | 4.39 Million USD | -3643.293% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -44.842% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -228309.44% |
| Orgenesis Inc. | 21.78 Million USD | -654.535% |
| Entera Bio Ltd. | -10.62 Million USD | 1646.411% |
| GH Research PLC | -78.07 Million USD | 310.52% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 837.473% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 716.557% |
| Xencor, Inc. | 29.64 Million USD | -454.473% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 8444.35% |
| Replimune Group, Inc. | 1.41 Million USD | -11540.793% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 67214.182% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 230.02% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 13934.118% |
| Portage Biotech Inc. | -4.98 Million USD | 3399.9% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 730786.824% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 348.583% |
| OncoCyte Corporation | -6.56 Million USD | 2604.464% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -18215.759% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 3708.009% |
| Purple Biotech Ltd. | -14.13 Million USD | 1262.597% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 791.901% |
| scPharmaceuticals Inc. | -6.54 Million USD | 2611.352% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 1084.702% |
| HilleVax, Inc. | -165.48 Million USD | 199.325% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 6576.281% |
| Tharimmune, Inc. | -10.93 Million USD | 1603.088% |
| Genprex, Inc. | -6.73 Million USD | 2539.553% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 144.567% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 285.811% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 11832.191% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 5055.402% |
| OKYO Pharma Limited | -826.84 Thousand USD | 19978.865% |
| Savara Inc. | 153 Thousand USD | -107330.066% |
| Curis, Inc. | -23.88 Million USD | 788.107% |
| Daré Bioscience, Inc. | -5.15 Million USD | 3286.717% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 21281.116% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 2747.68% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -13770.717% |
| BeiGene, Ltd. | -2.25 Billion USD | 107.295% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -1232.155% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 127.025% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 188.567% |
| Erasca, Inc. | -37.21 Million USD | 541.66% |
| bluebird bio, Inc. | 108.57 Million USD | -51.392% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 12862.551% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 56.602% |
| DBV Technologies S.A. | -126.98 Million USD | 229.438% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 12862.551% |
| Moderna, Inc. | -2.9 Billion USD | 105.654% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 1687.79% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 1612.403% |
| Molecular Templates, Inc. | 707 Thousand USD | -23148.656% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 623.949% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 52.578% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 300.297% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 279.187% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 609.321% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 578.148% |
| MacroGenics, Inc. | -66.98 Million USD | 345.38% |
| RenovoRx, Inc. | -1.17 Million USD | 14112.617% |
| Adicet Bio, Inc. | -138.78 Million USD | 218.432% |
| Prime Medicine, Inc. | -27.94 Million USD | 688.268% |
| Aditxt, Inc. | 18.12 Million USD | -807.064% |
| Adagene Inc. | -87.62 Million USD | 287.576% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 4046.005% |
| Quantum-Si incorporated | -118.55 Million USD | 238.64% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -356.514% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 2299.142% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 438.84% |
| SciSparc Ltd. | -2.06 Million USD | 8059.709% |
| Vericel Corporation | 1.27 Million USD | -12771.417% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 1470.681% |
| Minerva Neurosciences, Inc. | 41 Million USD | -300.856% |
| Generation Bio Co. | 31.44 Million USD | -422.666% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 193.73% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 631.54% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -40.976% |
| Invivyd, Inc. | -198.47 Million USD | 182.815% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 282.085% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 6955.27% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 332.191% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 2508.322% |
| 2seventy bio, Inc. | 181.71 Million USD | 9.546% |
| ADMA Biologics, Inc. | 90.06 Million USD | -82.497% |
| Clene Inc. | 3.34 Million USD | -4821.198% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 1909.682% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 864.111% |
| GeoVax Labs, Inc. | -6.45 Million USD | 2647.319% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 147.764% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 732.192% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 7.485% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 4117.238% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -3186.046% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 3255.462% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 226.142% |
| Evaxion Biotech A/S | 5.28 Million USD | -3009.0% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 246.017% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 225.211% |
| Trevena, Inc. | 2.25 Million USD | -7179.362% |
| Surrozen, Inc. | -32.66 Million USD | 603.208% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 419.099% |
| Cingulate Inc. | 3.08 Million USD | -5231.979% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 5696.459% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -2187.018% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 1869.067% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 307.214% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 225.04% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 255.737% |
| Clearmind Medicine Inc. | -3.94 Million USD | 4268.986% |
| Kronos Bio, Inc. | -36.05 Million USD | 555.894% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -1646.923% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -11172.544% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 402.949% |
| Statera Biopharma, Inc. | 14.41 Million USD | -1040.145% |
| ImmunityBio, Inc. | 618.22 Million USD | 73.413% |
| Korro Bio, Inc. | -132.94 Million USD | 223.638% |
| Kineta, Inc. | -4.54 Million USD | 3719.643% |
| BioVie Inc. | -17.73 Million USD | 1026.939% |
| Codexis, Inc. | -43.27 Million USD | 479.857% |
| Celularity Inc. | 65.19 Million USD | -152.137% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 5286.747% |
| Celcuity Inc. | 6.78 Million USD | -2323.053% |
| Virax Biolabs Group Limited | -3.36 Million USD | 4984.717% |
| Cibus, Inc. | -8.07 Million USD | 2134.761% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 3986.687% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -3496.674% |
| IN8bio, Inc. | -16.38 Million USD | 1102.917% |
| Kodiak Sciences Inc. | -103.87 Million USD | 258.236% |
| Annexon, Inc. | -193.75 Million USD | 184.833% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -456477.781% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 1039.299% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 4778.85% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 84.409% |
| Eyenovia, Inc. | 1.25 Million USD | -12958.532% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -510.92% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 5168.393% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 594.384% |
| Arcellx, Inc. | -296.95 Million USD | 155.351% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 942.654% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 379.181% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 893.014% |
| Moolec Science SA | 117.61 Thousand USD | -139649.695% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 528.053% |
| Geron Corporation | 14.76 Million USD | -1013.529% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 533.483% |
| Royalty Pharma plc | 5.65 Billion USD | 97.095% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 216.226% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 2451.667% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 3164.932% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 216.796% |
| Humacyte, Inc. | -22.48 Million USD | 830.979% |
| Structure Therapeutics Inc. | -124.33 Million USD | 232.193% |
| 89bio, Inc. | -289.05 Million USD | 156.864% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 751.169% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 9318.62% |
| Genelux Corporation | -6.89 Million USD | 2482.49% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 629.212% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -96.615% |
| Notable Labs, Ltd. | -9.77 Million USD | 1781.342% |
| Liquidia Corporation | -80.17 Million USD | 305.009% |
| Mustang Bio, Inc. | -3.73 Million USD | 4499.572% |
| Immunovant, Inc. | -635.22 Million USD | 125.875% |
| Quantum-Si incorporated | -118.55 Million USD | 238.64% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 1035.823% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 4067.367% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -1947.689% |
| Acasti Pharma Inc. | -23 Million USD | 814.488% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 4981.403% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 1111.534% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 219.332% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 5374.355% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 839.331% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 985.174% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 197.099% |
| PepGen Inc. | -60.67 Million USD | 370.921% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 815.39% |
| United Therapeutics Corporation | -507.7 Million USD | 132.375% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 959.396% |
| Solid Biosciences Inc. | -47.75 Million USD | 444.226% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 19166.245% |
| Immuneering Corporation | -54.94 Million USD | 399.162% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 4010.276% |
| Silo Pharma, Inc. | -3.52 Million USD | 4763.838% |
| Belite Bio, Inc | -87.27 Million USD | 288.342% |
| XOMA Corporation | -29 Million USD | 666.786% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 332.496% |
| Bionomics Limited | 227 Million USD | 27.594% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 241.353% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 6589.064% |
| uniQure N.V. | -102.95 Million USD | 259.657% |
| Cassava Sciences, Inc. | -121.13 Million USD | 235.689% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 4046.005% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -301.377% |
| Forte Biosciences, Inc. | -11.96 Million USD | 1474.199% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 5412.132% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -154964.152% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 5168.393% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -1745.795% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 2316.397% |
| Altimmune, Inc. | -134.48 Million USD | 222.219% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 17.013% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 6589.064% |
| Compugen Ltd. | -12.9 Million USD | 1373.776% |
| Peak Bio, Inc. | 10.34 Million USD | -1489.608% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 58180.566% |
| Benitec Biopharma Inc. | -50.58 Million USD | 424.954% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 257.534% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -736.691% |
| Zura Bio Limited | -99.8 Million USD | 264.687% |
| PolyPid Ltd. | 6.17 Million USD | -2563.987% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -121.759% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -736.691% |
| Instil Bio, Inc. | 75.35 Million USD | -118.116% |
| argenx SE | -2.02 Billion USD | 108.102% |
| Immunome, Inc. | -97.02 Million USD | 269.401% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 830.687% |
| Verona Pharma plc | -220.44 Million USD | 174.563% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 329.107% |
| Shattuck Labs, Inc. | -121.42 Million USD | 235.367% |
| CervoMed Inc. | -7.79 Million USD | 2209.217% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 188.609% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 3858.701% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 224.767% |
| Moolec Science SA | 117.61 Thousand USD | -139649.695% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 7283.988% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -933.866% |
| AnaptysBio, Inc. | -18.15 Million USD | 1005.559% |
| Design Therapeutics, Inc. | -18.15 Million USD | 1005.609% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 333.54% |
| NeurAxis, Inc. | 145.7 Thousand USD | -112712.629% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -1363.39% |
| Lumos Pharma, Inc. | -28.49 Million USD | 676.872% |
| Achilles Therapeutics plc | -126.92 Million USD | 229.501% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 329.107% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 25166.415% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 891.226% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -11172.544% |
| Nutriband Inc. | -251.65 Thousand USD | 65414.297% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 1347.954% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 2309.247% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 51.684% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -592.513% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 136.733% |
| Palisade Bio, Inc. | -12.06 Million USD | 1462.58% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 217.145% |
| Beam Therapeutics Inc. | -262.72 Million USD | 162.563% |
| Neurogene Inc. | -131.95 Million USD | 224.564% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -653.429% |
| AEON Biopharma, Inc. | -4.88 Million USD | 3468.197% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 143.577% |
| Sesen Bio, Inc. | -112.55 Million USD | 246.036% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 264.598% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 7100.958% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 521.176% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 297.363% |
| Athira Pharma, Inc. | -88.99 Million USD | 284.685% |
| Vaccinex, Inc. | -1.28 Million USD | 12861.491% |
| HCW Biologics Inc. | 2.85 Million USD | -5653.82% |
| XOMA Corporation | -29 Million USD | 666.786% |
| Nektar Therapeutics | 210.24 Million USD | 21.819% |
| Arvinas, Inc. | -313.8 Million USD | 152.38% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -10028.105% |
| Merus N.V. | -192.88 Million USD | 185.216% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -174.015% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 2469.098% |
| Rezolute, Inc. | -68.16 Million USD | 341.122% |
| Clene Inc. | 3.34 Million USD | -4821.198% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 1346.44% |
| BeyondSpring Inc. | -13.75 Million USD | 1294.969% |
| Synlogic, Inc. | -6.68 Million USD | 2558.758% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -14394.533% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 2044.033% |
| Peak Bio, Inc. | 10.34 Million USD | -1489.608% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 299.427% |
| Krystal Biotech, Inc. | -350.23 Million USD | 146.931% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -32.421% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 197.261% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 5306.224% |
| MannKind Corporation | 143.89 Million USD | -14.225% |
| Ikena Oncology, Inc. | -109.15 Million USD | 250.581% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 2271.021% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 596.58% |
| Gossamer Bio, Inc. | 180.35 Million USD | 8.864% |
| CohBar, Inc. | -5.93 Million USD | 2871.463% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 652.535% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -3499.825% |
| Legend Biotech Corporation | -949.39 Million USD | 117.313% |
| Mural Oncology plc | -255.84 Million USD | 164.246% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -410.222% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 3589.291% |
| Disc Medicine, Inc. | -358.28 Million USD | 145.877% |
| Champions Oncology, Inc. | 4.81 Million USD | -3315.794% |
| REGENXBIO Inc. | 54.76 Million USD | -200.117% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 61224.478% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 208.836% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 1923.878% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 303.721% |
| Vaxart, Inc. | -8.24 Million USD | 2094.515% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 427.557% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 229.255% |
| Cellectis S.A. | -43.85 Million USD | 474.799% |
| Longeveron Inc. | -2.9 Million USD | 5752.27% |
| Repare Therapeutics Inc. | -107.85 Million USD | 252.393% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 83.026% |
| Inozyme Pharma, Inc. | 12 Million USD | -1269.277% |
| Revolution Medicines, Inc. | -608.2 Million USD | 127.025% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 13463.252% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 161.998% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 209.526% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 1150.476% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 22311.892% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 101.719% |
| Denali Therapeutics Inc. | -74.86 Million USD | 319.553% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 1470.681% |
| Veru Inc. | 4.77 Million USD | -3338.683% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 1561.569% |
| Cingulate Inc. | 3.08 Million USD | -5231.979% |
| Passage Bio, Inc. | 4.58 Million USD | -3484.907% |
| Context Therapeutics Inc. | -14.44 Million USD | 1237.508% |
| Exicure, Inc. | 5.84 Million USD | -2710.19% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 171.348% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 515.385% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -947.53% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 379.438% |
| Nuvalent, Inc. | -335.38 Million USD | 149.008% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -9377.26% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 320.682% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 1948.909% |
| OmniAb, Inc. | 9.2 Million USD | -1686.026% |
| Anew Medical, Inc. | 1.43 Million USD | -11374.486% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -903.36% |
| Lipocine Inc. | -4.75 Million USD | 3557.037% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 249.659% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -979.167% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 424.46% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -560.325% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 2545.588% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 349.697% |
| Ocugen, Inc. | -32.52 Million USD | 605.421% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 292.075% |
| Q32 Bio Inc. | -37.94 Million USD | 533.14% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 26273.249% |
| Alumis Inc. Common Stock | -13.52 Million USD | 1314.931% |
| Equillium, Inc. | -22.39 Million USD | 834.048% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 742.866% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 603.783% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 66400.144% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -22.624% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -5039.712% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -49944.909% |
| Dominari Holdings Inc. | 195 Thousand USD | -84191.283% |
| Edesa Biotech, Inc. | -5.26 Million USD | 3220.767% |
| vTv Therapeutics Inc. | -8.91 Million USD | 1943.311% |
| Bio-Techne Corporation | 267.74 Million USD | 38.611% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 1114.054% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 239.184% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 2056.063% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 1399.249% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 167.056% |
| Nkarta, Inc. | 57.29 Million USD | -186.86% |
| BioCardia, Inc. | 212 Thousand USD | -77432.076% |
| Iterum Therapeutics plc | 13.43 Million USD | -1123.158% |